Skip to main content

Breast Magnetic Resonance Imaging Techniques

  • Chapter
Breast MRI

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003;98:468–473.

    Article  PubMed  Google Scholar 

  2. Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110–119.

    PubMed  CAS  Google Scholar 

  3. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881–888.

    PubMed  CAS  Google Scholar 

  4. Kneeshaw PJ, Turnbull LW, Smith A, et al. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol. 2003;29:32–37.

    Article  PubMed  CAS  Google Scholar 

  5. Kuhl CK. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). J Exp Clin Cancer Res. 2002;21(Suppl 3):103–106.

    PubMed  CAS  Google Scholar 

  6. Leach MO, Eeles RA, Turnbull LW, et al. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res. 2002;21(Suppl 3):107–114.

    PubMed  CAS  Google Scholar 

  7. Morris EA, Liberman E, Balloon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol. 2003;181:619–626.

    PubMed  Google Scholar 

  8. Esserman L, Kaplan E, Partridge S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol. 2001;8:549–559.

    PubMed  CAS  Google Scholar 

  9. Wasser K, Klein SK, Fink C, et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol. 2003;13: 80–87.

    PubMed  CAS  Google Scholar 

  10. Delille JP, Slanetz PJ, Yeh ED, et al. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 2003;228:63–69.

    PubMed  Google Scholar 

  11. Daniel BL, Yen YF, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology 1998;209:499–509.

    PubMed  CAS  Google Scholar 

  12. Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed. 2002;15:154–163.

    Article  PubMed  Google Scholar 

  13. Nagashima T, Suzuki M, Yagata H, et al. Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer 2002;9:226–230.

    Article  PubMed  Google Scholar 

  14. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging. 1999;10:260–266.

    PubMed  CAS  Google Scholar 

  15. Stomper PC, Winston JS, Herman S, et al. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat. 1997;45:39–46.

    PubMed  CAS  Google Scholar 

  16. Esserman L, Hylton N, George T, et al. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J. 1999;5:13–21.

    Article  PubMed  Google Scholar 

  17. Mussurakis S, Buckley DL, Bowsley SJ, et al. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Invest Radiol. 1995;30:650–662.

    PubMed  CAS  Google Scholar 

  18. Hylton NM. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am. 1999;7:411–420, x.

    PubMed  CAS  Google Scholar 

  19. Henderson E, Rutt BK, Lee TY. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging. 1998;16:1057–1073.

    PubMed  CAS  Google Scholar 

  20. Song HK, Dougherty L, Schnall MD. Simultaneous acquisition of multiple resolution images for dynamic contrast enhanced imaging of the breast. Magn Reson Med. 2001;46:503–509.

    PubMed  CAS  Google Scholar 

  21. Harms SE, Flamig DP. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493–501.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Hylton, N.M. (2005). Breast Magnetic Resonance Imaging Techniques. In: Breast MRI. Springer, New York, NY. https://doi.org/10.1007/0-387-27595-9_2

Download citation

  • DOI: https://doi.org/10.1007/0-387-27595-9_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-21997-4

  • Online ISBN: 978-0-387-27595-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics